BRIEF-Biomarin- gets European orphan drug designation for Gene Therapy drug for Hemop
 

BRIEF-Biomarin- gets European orphan drug designation for Gene Therapy drug for Hemophilia A
* Receives European orphan drug designation for bmn 270,first investigational aav-factor viii gene therapy for patientswith hemophilia aSource text for Eikon: Further company coverage:http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...7A:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...7A:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/YMS2gzz8mjs